CytoSorb in Patients With Liver Failure

Institutul Clinic Fundeni

Status: Completed

Conditions: Liver Dysfunction

Treatments: Procedure: hemoadsorption

Study type: Observational

Funder types: Other

Identifiers

NCT04511507

Cyto-ALF

Details and patient eligibility

About

Hemoadsorption has been demonstrated to improve liver functional tests in patients with liver failure. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with acute liver failure, on liver functional tests, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

Enrollment: 35 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with acute liver failure or acute on chronic liver failure who require hemoadsorption in accordance with local guidelines

Exclusion criteria

• unsigned informed consent
• duration of therapy under 12 hours
• death before the three consecutive sessions

Trial design

35 participants in 1 patient group

liver failure

Description:

patients diagnosed with acute liver failure or acute on chronic liver failure in accordance with national guidelines who require 3 consecutive sessions of hemoadsorption

Treatment:

Procedure: hemoadsorption